Catalyst Wire Dossier Catalyst Wire Dossier

dolutegravir dispersible tablets

dolutegravir
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for dolutegravir dispersible tablets, covering 2021-11-23 to 2021-11-23. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIV [Phase 2]

See pricing